EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Vanda Pharmaceuticals Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) resulting from allegations that Vanda may have issued materially misleading business information to the investing public.

On February 11, 2019, Aurelius Value published an article which discussed a 150-page whistleblower lawsuit alleging that, “Vanda has engaged in a series of fraudulent schemes, some personally orchestrated by [its CEO], to defraud government payors.” The whistleblower lawsuit alleges “illegal off-label promotion of both of Vanda’s drugs, Vanda’s participation in a fraud involving doctors writing hundreds of ‘fake prescriptions’ and pocketing cash using Vanda-issued copay cards, falsified documents in internal systems, and resignations of senior executives who refused to participate in illegal activity.” On this news, shares of Vanda securities fell during intra-day trading on February 11, 2019.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Vanda investors. If you purchased shares of Vanda please visit the firm’s website at https://www.rosenlegal.com/cases-1504.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190211005569/en/